Abbal Koirala, MD - Rituximab in the management of MCD and immune mediated FSGS
powernephron
Published on Dec 13, 2022
University of Washington Nephrology Grand Rounds - December 2, 2022
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:05:18MCD vs. FSGS: Breakdown of Diagnostics and Clinical Course
47 views 876 days ago -
Watch Later
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
46 views 909 days ago -
Watch Later
29:13 -
Watch Later
![Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant]()
01:20:15Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant
47 views 868 days ago -
Watch Later
![KDIGO-ISN Webinar on the New KDIGO Glomerular Diseases Guideline: LN & FSGS]()
01:07:54KDIGO-ISN Webinar on the New KDIGO Glomerular Diseases Guideline: LN & FSGS
50 views 1161 days ago -
Watch Later
![Recurrent FSGS: What’s New? - UCSF Kidney Transplant Program - Update in Transplantation 2013]()
33:04
